Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -4.29EBITDA per Share
VS
Market
Sector
Industry
History
$ 0.45Close
$ 0.37 - $ 2.16 52-Week Range
Ticker Information
Ticker
TOVXCompany Name
THERIVA BIOLOGICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTTHERIVA BIOLOGICS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TOVX - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -28.94M | $ -4.29 | 1 | 6.75M |
| 3/31/2025 | $ -24.23M | $ -8.71 | 1 | 2.78M |
| 12/31/2024 | $ -25.06M | $ -18.59 | 1 | 1.35M |
| 9/30/2024 | $ -26.53M | $ -23.38 | 1 | 1.13M |
| 6/30/2024 | $ -22.67M | $ -29.22 | 1 | 775.74K |
| 3/31/2024 | $ -19.71M | $ -28.73 | 1 | 685.92K |
| 12/31/2023 | $ -19.47M | $ -30.21 | 1 | 644.28K |
| 9/30/2023 | $ -20.69M | $ -30.35 | 1 | 681.71K |
| 6/30/2023 | $ -21.83M | $ -35.98 | 1 | 606.65K |
| 3/31/2023 | $ -21.55M | $ -35.62 | 1 | 604.96K |
Key Performance Insights, Last 5 Years
- THERIVA BIOLOGICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -139.79.
- Over the past 5 years, THERIVA BIOLOGICS INC's average EBITDAPS has been $ -36.51.
- The median EBITDAPS for THERIVA BIOLOGICS INC during this period was $ -28.95
- THERIVA BIOLOGICS INC reached its highest EBITDAPS over the past 5 years at $ -4.29.
- The lowest EBITDAPS recorded by THERIVA BIOLOGICS INC in the same timeframe $ -139.79
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for THERIVA BIOLOGICS INC is calculated as follows: EBITDA [ $ -10.85M ] / (Shares WA [ 77.59K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -139.79 ] TOVX - EBITDA per Share, Last 5 years
$ -139.79
Minimum
Sep 30, 2020
$ -4.29
Maximum
Jun 30, 2025
$ -36.51
Average
$ -28.95
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 14.03 |
| average | $ 2.03 |
| median | $ 1 |
| std | $ 4.28 |